Are you Dr. Bai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6411 Fannin St
Houston, TX 77030Phone+1 713-500-5300Fax+1 713-500-0730
Summary
- Dr. Yu Bai, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and Virginia. She is affiliated with Memorial Hermann - Texas Medical Center and Memorial Hermann Physician Network.
Education & Training
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2002- University of Virginia Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2000 - 2001
Beijing Medical UniversityClass of 1987
Certifications & Licensure
TX State Medical License 2005 - 2025
VA State Medical License 1998 - 2024- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 173 citationsA randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions.Bryan A. Cotton, Jeanette M. Podbielski, Elizabeth A. Camp, Timothy Welch, Deborah J. del Junco
Annals of Surgery. 2013-10-01 - 704 citationsThe prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risksJohn B. Holcomb, Deborah J. del Junco, Erin E. Fox, Charles E. Wade, Mitchell J. Cohen
JAMA Surgery. 2013-02-01 - 3 citationsPathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.Kerry J. Welsh, Yu Bai
American Journal of Clinical Pathology. 2016-06-01
Press Mentions
Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled TrialNovember 18th, 2020- Prevalence of Gastric Cancer Precursors in Gastroscopy-Screened Adults by Family History of Gastric Cancer and of Cancers Other Than GastricNovember 16th, 2020
- Dizal Highlights Its Advances in Hematological Portfolio at 2023 ASH, Featuring Breakthroughs in Lymphoma TreatmentNovember 4th, 2023
- Join now to see all
